NAS:COEP (USA)
Â
Ordinary Shares
$
0.20
+0.004 (+2.04%)
12:09 AM EST
Business Description
Coeptis Therapeutics Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US19207A1088
Share Class Description:
COEP: Ordinary SharesDescription
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.64 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -22.7 | |||||
| 3-Year EPS without NRI Growth Rate | -23.9 | |||||
| 3-Year FCF Growth Rate | -22.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 40.91 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.94 | |||||
| 9-Day RSI | 53.68 | |||||
| 14-Day RSI | 51.88 | |||||
| 6-1 Month Momentum % | -20.08 | |||||
| 12-1 Month Momentum % | -82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.4 | |||||
| Quick Ratio | 0.4 | |||||
| Cash Ratio | 0.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20 | |||||
| Shareholder Yield % | -28.64 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -398.88 | |||||
| ROA % | -169.45 | |||||
| ROIC % | -200.83 | |||||
| ROC (Joel Greenblatt) % | -13472.55 | |||||
| ROCE % | -308.17 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.65 | |||||
| Price-to-Tangible-Book | 1.67 | |||||
| EV-to-EBIT | -0.78 | |||||
| EV-to-Forward-EBIT | -2.93 | |||||
| EV-to-EBITDA | -0.86 | |||||
| EV-to-Forward-EBITDA | -2.93 | |||||
| EV-to-FCF | -1.28 | |||||
| Earnings Yield (Greenblatt) % | -128.21 | |||||
| FCF Yield % | -83.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:COEP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Coeptis Therapeutics Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.28 | ||
| Beta | 0 | ||
| Volatility % | 62.32 | ||
| 14-Day RSI | 51.88 | ||
| 14-Day ATR ($) | 0.016986 | ||
| 20-Day SMA ($) | 0.19855 | ||
| 12-1 Month Momentum % | -82 | ||
| 52-Week Range ($) | 0.1511 - 1.28 | ||
| Shares Outstanding (Mil) | 41.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coeptis Therapeutics Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Coeptis Therapeutics Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Coeptis Therapeutics Holdings Inc Frequently Asked Questions
What is Coeptis Therapeutics Holdings Inc(COEP)'s stock price today?
The current price of COEP is $0.20. The 52 week high of COEP is $1.28 and 52 week low is $0.15.
When is next earnings date of Coeptis Therapeutics Holdings Inc(COEP)?
The next earnings date of Coeptis Therapeutics Holdings Inc(COEP) is 2025-02-08 Est..
Does Coeptis Therapeutics Holdings Inc(COEP) pay dividends? If so, how much?
Coeptis Therapeutics Holdings Inc(COEP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers